Saturday Edition
Stay updated with Archyde – your source for breaking news, global headlines, economy, entertainment, health, technology, and sports. Fresh stories daily.
Novo Nordisk’s oral semaglutide (Rybelsus) has achieved a 17% average weight loss in the OASIS-4 trial, marking a landmark milestone for obesity pharmacotherapy. Approved this week in the UAE, the ... Read More
Continuous Coverage
On June 4, 2026, Hampshire and Isle of Wight Chief Constable Alexis Boon issued a formal apology for…
A viral Reddit thread featuring a player running Forza Horizon 6 on a smart refrigerator has sparked a…
Cricket Victoria is spearheading a radical consolidation of the Melbourne Stars and Melbourne Renegades, aiming to merge the…
ASUS and Ventiva test fanless cooling for AI mini-PCs, aiming to redefine thermal efficiency in compact computing. The…
Starlux Airlines (OTC: STLXF), Taiwan’s premium carrier, is quietly reshaping Asia-Pacific air travel with its business-class product—now benchmarked…
On a sweltering June morning in 2026, a quiet but seismic shift in Central Asian geopolitics unfolded in…
Global Affairs
In a pivotal move, the U.S. House of Representatives passed a resolution curbing former President Donald Trump’s executive…
Markets And Money
Peru’s Loto Plus (operated by Casino de Lima (NYSE: CZL)) drew its 3,888th draw on June 3, 2026,…
Digital Culture
007 First Light, the latest tactical espionage title from IO Interactive, shifts the genre from traditional run-and-gun mechanics…
Science And Wellbeing
Starting this week, the Dutch government has mandated that bariatric surgery—specifically gastric bypass and sleeve gastrectomy—be included in…
Screen And Sound
Ranveer Singh’s Don 3 exit sparks industry reckoning as FWICE retracts boycott, but legal tensions linger—The dispute over…
Fixtures And Form
Trent Alexander-Arnold’s public endorsement of a potential Liverpool reunion has reignited speculation regarding his Anfield future just days…
